TY - JOUR
T1 - Daily administered dual-light photodynamic therapy provides a sustained antibacterial effect on Staphylococcus aureus
AU - Nikinmaa, Sakari
AU - Podonyi, Anna
AU - Raivio, Peter
AU - Meurman, Jukka
AU - Sorsa, Timo
AU - Rantala, Juha
AU - Kankuri, Esko
AU - Tauriainen, Tuomas
AU - Pätilä, Tommi
N1 - Funding Information:
Funding: This research was supported by Instrumentarium Science Foundation. Koite Health Oy provided support in the form of salaries for author S.N. and provided the materials for the study (VAT-2918895-9). The specific roles of the authors are articulated in the Author Contributions section. The funders had no additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Funding Information:
This research was supported by Instrumentarium Science Foundation. Koite Health Oy provided support in the form of salaries for author S.N. and provided the materials for the study (VAT-2918895-9). The specific roles of the authors are articulated in the Author Contributions section. The funders had no additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/10
Y1 - 2021/10
N2 - New means to reduce excessive antibiotic use are urgently needed. This study tested dual-light aPDT against Staphylococcus aureus biofilm with different relative ratios of light energy with indocyanine green. We applied single-light aPDT (810 nm aPDT, 405 aBL) or dual-light aPDT (simultaneous 810 nm aPDT and 405 nm aBL), in both cases, together with the ICG photosensitizer with constant energy of 100 or 200 J/cm2. Single-dose light exposures were given after one-day, three-day, or six-day biofilm incubations. A repeated daily dose of identical light energy was applied during biofilm incubations for the three-and six-day biofilms. Using 100 J/cm2 light energy against the one-day biofilm, the dual-light aPDT consisting of more than half of aBL was the most effective. On a three-day maturated biofilm, single-dose exposure to aPDT or dual-light aPDT was more effective than aBL alone. With total light energy of 200 J/cm2, all dual-light treatments were effective. Dual-light aPDT improves the bactericidal effect on Staphylococcus aureus biofilm com-pared to aPDT or aBL and provides a sustained effect. An increase in the relative ratio of aBL strengthens the antibacterial effect, mainly when the treatment is repeatedly applied. Thus, the light components’ energy ratio is essential with dual-light.
AB - New means to reduce excessive antibiotic use are urgently needed. This study tested dual-light aPDT against Staphylococcus aureus biofilm with different relative ratios of light energy with indocyanine green. We applied single-light aPDT (810 nm aPDT, 405 aBL) or dual-light aPDT (simultaneous 810 nm aPDT and 405 nm aBL), in both cases, together with the ICG photosensitizer with constant energy of 100 or 200 J/cm2. Single-dose light exposures were given after one-day, three-day, or six-day biofilm incubations. A repeated daily dose of identical light energy was applied during biofilm incubations for the three-and six-day biofilms. Using 100 J/cm2 light energy against the one-day biofilm, the dual-light aPDT consisting of more than half of aBL was the most effective. On a three-day maturated biofilm, single-dose exposure to aPDT or dual-light aPDT was more effective than aBL alone. With total light energy of 200 J/cm2, all dual-light treatments were effective. Dual-light aPDT improves the bactericidal effect on Staphylococcus aureus biofilm com-pared to aPDT or aBL and provides a sustained effect. An increase in the relative ratio of aBL strengthens the antibacterial effect, mainly when the treatment is repeatedly applied. Thus, the light components’ energy ratio is essential with dual-light.
KW - Antibacterial photodynamic therapy
KW - Biofilm
KW - Staphylococcus aureus
UR - http://www.scopus.com/inward/record.url?scp=85117703740&partnerID=8YFLogxK
U2 - 10.3390/antibiotics10101240
DO - 10.3390/antibiotics10101240
M3 - Article
AN - SCOPUS:85117703740
SN - 2079-6382
VL - 10
JO - Antibiotics
JF - Antibiotics
IS - 10
M1 - 1240
ER -
